Drug Trial Radar · NCT00198562
Hypertension Control Based on Home Blood Pressure
Last checked: Nov 19, 2026Latest source record: Apr 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,600
Planned (sponsor's estimate)
Start
Apr 2000
Primary completion
Mar 2012
Study completion Mar 2012
Sponsor
- Lead sponsor
- Ministry of Health, Labour and Welfare, JapanGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Japan Cardiovascular Research Foundation
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs. The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. The study subjects are 40-79 years old hypertensive patients. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (morning home BP \<140 mmHg) or (2) strict control group (morning home BP \<130 mmHg), and to (a) amlodipine group or (b) losartan group. Additional antihypertensive drugs can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. The participants will be followed up for 5 years.
Conditions
- Hypertension
Interventions
Amlodipine, LosartanDrug
amlodipine: 2.5-10 mg once daily for 5 years losartan: 25-100 mg once daily for 5 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Combined cardiovascular eventsTime frame: 5 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Cardiovascular Center
Suita, Osaka, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.